{
    "title": "British drugs giant AstraZeneca pounces on rival Alexion in deal worth \u00a329.5bn",
    "url": "https://www.dailymail.co.uk/money/markets/article-9046885/AstraZeneca-pounces-rival-Alexion-deal-worth-29-5bn.html",
    "date": "2020-12-12",
    "keywords": [
        "alexion",
        "share",
        "deal",
        "acquisition",
        "expertise",
        "disease",
        "immunology",
        "executive",
        "cent",
        "statement",
        "cash",
        "fund",
        "astra",
        "cambridge",
        "access",
        "blood",
        "soriot",
        "shot",
        "arm",
        "portfolio",
        "investment",
        "account",
        "fee",
        "astrazeneca",
        "rival",
        "yesterday",
        "turnaround",
        "business",
        "year",
        "sweden",
        "friday",
        "firm",
        "ftse100",
        "swoop",
        "speculation",
        "companys",
        "valuation",
        "leverage",
        "core",
        "focus",
        "development",
        "cancer",
        "respiratory",
        "renal",
        "company",
        "pharmas",
        "eu",
        "vaccine",
        "side",
        "article",
        "precision",
        "innovation",
        "quarter",
        "chief",
        "ludwig",
        "hantson",
        "pipeline",
        "workforce",
        "manufacturing",
        "offer",
        "adr",
        "stock",
        "mechanism",
        "trading",
        "nonus",
        "financing",
        "stanley",
        "jp",
        "morgan",
        "goldman",
        "sachs",
        "bank",
        "agreement",
        "portion",
        "generation",
        "capital",
        "risk",
        "isa",
        "trade",
        "month",
        "community",
        "model",
        "affiliate",
        "product",
        "money",
        "commission",
        "editorial",
        "independence",
        "investing",
        "platform"
    ],
    "category": [
        "money",
        "markets"
    ]
}